JP2002533400A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533400A5
JP2002533400A5 JP2000590649A JP2000590649A JP2002533400A5 JP 2002533400 A5 JP2002533400 A5 JP 2002533400A5 JP 2000590649 A JP2000590649 A JP 2000590649A JP 2000590649 A JP2000590649 A JP 2000590649A JP 2002533400 A5 JP2002533400 A5 JP 2002533400A5
Authority
JP
Japan
Prior art keywords
subject
viral infection
administering
treat
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000590649A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/031161 external-priority patent/WO2000038697A1/en
Publication of JP2002533400A publication Critical patent/JP2002533400A/ja
Publication of JP2002533400A5 publication Critical patent/JP2002533400A5/ja
Pending legal-status Critical Current

Links

JP2000590649A 1998-12-29 1999-12-29 Hiv及び他のウイルス感染の治療及び予防 Pending JP2002533400A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11454098P 1998-12-29 1998-12-29
US60/114,540 1998-12-29
PCT/US1999/031161 WO2000038697A1 (en) 1998-12-29 1999-12-29 Treatment and prevention of hiv and other viral infections

Publications (2)

Publication Number Publication Date
JP2002533400A JP2002533400A (ja) 2002-10-08
JP2002533400A5 true JP2002533400A5 (https=) 2007-02-22

Family

ID=22355871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590649A Pending JP2002533400A (ja) 1998-12-29 1999-12-29 Hiv及び他のウイルス感染の治療及び予防

Country Status (6)

Country Link
EP (1) EP1143981B1 (https=)
JP (1) JP2002533400A (https=)
AT (1) ATE335494T1 (https=)
AU (1) AU2396900A (https=)
DE (1) DE69932741D1 (https=)
WO (1) WO2000038697A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049672A2 (en) * 2001-10-30 2003-06-19 Microbiotix, Inc. Methods and compositions for treating flavivirus-mediated disease
EP1773363A4 (en) * 2004-07-19 2010-01-27 Life Science Nutrition As NGNA COMPOSITIONS AND APPLICATION PROCEDURES
US20100119558A1 (en) 2008-11-10 2010-05-13 Scandivir Ab Ngna compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287598A (ja) * 1985-10-11 1987-04-22 Mect Corp N−グリコリルノイラミン酸誘導体
EP0727216B1 (en) * 1994-07-15 2003-05-28 TAIYO KAGAKU Co., LTD. Medicinal composition containing sialic acid derivative

Similar Documents

Publication Publication Date Title
EA200201263A1 (ru) СПОСОБЫ ЛЕЧЕНИЯ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ВИРУСОМ ГЕПАТИТА ДЕЛЬТА, С ИСПОЛЬЗОВАНИЕМ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
TW200505901A (en) Muscarinic agonists
MXPA01009544A (es) Metodo para tratar y/o prevenir enfermedades retinales con corticosteroides de liberacion sostenida.
WO2001096353A3 (en) 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES
PL365985A1 (en) 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions
WO2001068096A3 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
MY119375A (en) Treatment of tinnitus using neuroprotective agents
WO2003063573A3 (en) Method for treating diseases with omega interferon
IL153733A0 (en) A new use for deferiprone
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
EP1295611A4 (en) COMPOUNDS FOR THE TRANSFER OF OLIGONUCLEOTIDES (03.01.02)
JP2002533400A5 (https=)
ZA200402232B (en) Method for treating hepatitis C virus infection in treatment failure patients.
WO2001085188A3 (en) Use of echinacea as a hematinic agent
ITRM990309A0 (it) Composizione per il trattamento del prurito uremico e di forme di prurito non riconducibili a lesioni organiche.
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
WO2002076400A3 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
EP1270000A3 (en) Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
Bodansky et al. What makes international agreements effective?: some pointers for the WHO Framework Convention on Tobacco Control
RU99122488A (ru) Способ лечения рака эндометрия